MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00247-025-06359-3

Медицинская библиотека · Pediatric radiology · 2025

Early radiologic tumour volume response in non-metastatic rhabdomyosarcoma is not predictive for survival.

de Vries Isabelle S A, Morosi Carlo, Bisogno Gianni, Minard-Colin Veronique, Coppadoro Beatrice, Zanetti Ilaria, Ferrari Andrea, Orbach Daniel, Moalla Salma, Ben-Arush Myriam, Devalck Christine, van Ewijk Roelof, McHugh Kieran, Jenney Meriel, Chisholm Julia, Guillen Gabriela, Mandeville Henry, Merks Johannes H M, Van Rijn Rick R

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

There is an urgent need for early radiological markers predicting survival in paediatric rhabdomyosarcoma patients.

OBJECTIVE

To analyse the predictive value of early radiological tumour volume response to chemotherapy in non-metastatic rhabdomyosarcoma patients.

METHODS

The European paediatric Soft tissue sarcoma Study Group (EpSSG) RMS 2005 study prospectively included non-metastatic rhabdomyosarcoma patients. Patients with Intergroup Rhabdomyosarcoma Studies (IRS) postsurgical Group III (i.e. measurable disease) at diagnosis, with three tumour diameters available at diagnosis and following three cycles of chemotherapy, were included. Tumour response was categorized as complete response, partial response, minor partial response, stable disease, or progressive disease. Patients with progressive disease were excluded from analyses. Failure-free survival and overall survival were estimated with Kaplan-Meier using a landmark analysis. Prognostic factors were assessed using Cox proportional hazards analyses.

RESULTS

Of 1,674 patients aged < 18 years at diagnosis included in the EpSSG RMS 2005 study, 613 patients (median age 4.2 years, interquartile range 2.2-8.0, 346 males) were eligible for analysis. After three cycles of chemotherapy, 48 patients reached complete response, 371 partial response, 139 minor partial response, 48 stable disease, and seven patients progressive disease. Univariate Cox proportional hazards model showed no significant difference between response groups for failure-free survival or overall survival. In multivariate Cox regression analysis, tumour volume response was not an independent prognostic factor for failure-free survival or overall survival.

CONCLUSION

Early radiological tumour volume response after the third cycle of neoadjuvant chemotherapy, with exclusion of progressive disease, does not predict survival in paediatric rhabdomyosarcoma patients.

Для цитирования: de Vries Isabelle S A, Morosi Carlo, Bisogno Gianni, Minard-Colin Veronique, Coppadoro Beatrice, Zanetti Ilaria, Ferrari Andrea, Orbach Daniel, Moalla Salma, Ben-Arush Myriam, Devalck Christine, van Ewijk Roelof, McHugh Kieran, Jenney Meriel, Chisholm Julia, Guillen Gabriela, Mandeville Henry, Merks Johannes H M, Van Rijn Rick R. Early radiologic tumour volume response in non-metastatic rhabdomyosarcoma is not predictive for survival.. Pediatric radiology. 2025. DOI: 10.1007/s00247-025-06359-3.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.